Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Americas
Published
2025-02-22
DOI
https://doi.org/10.1016/j.lana.2025.101031
Citations
1
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil

Haley Hedlin, Stephen P. Luby, Di Lu, Patrícia Vieira da Silva et al.
1 citations
The Lancet Regional Health - Americas
SARS-CoV-2 and COVID-19 Research
1.40
article

Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil

Haley Hedlin, Stephen P. Luby, Di Lu, Patrícia Vieira da Silva, Vivek Charu, Roberto Dias de Oliveira, Jessica Couvillion Seidman, Amy Zhang, Marco Antonio Moreira Puga, Blake Shaw, Joelle I. Rosser, Denise O. Garrett, Júlio Croda, Farah Naz Qamar, Alice Carter
article en
1 citations

Abstract

No abstract available for this paper.
The Lancet Regional Health - AmericasVol. 44
Aga Khan University (PK), Universidade Federal de Mato Grosso do Sul (BR), European Union of Medical Specialists (BE), Universidade Federal da Grande Dourados (BR), Universidade Estadual de Mato Grosso do Sul (BR), Yale University (US), Stanford Medicine (US), Sabin Vaccine Institute (US), Fundação Oswaldo Cruz (BR), Stanford University (US)
Foundation for the National Institutes of Health, Sabin Vaccine Institute, Coalition for Epidemic Preparedness Innovations, National Institutes of Health, Stanford Bio-X, National Center for Research Resources, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 24%
SARS-CoV-2 and COVID-19 Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.